Literature DB >> 22634541

Evaluation of a mitochondrial DNA mutation in maternally inherited and sporadic cases of Dupuytren disease.

Eric R Anderson1, James K Burmester, Michael D Caldwell.   

Abstract

OBJECTIVE: The purpose was to test the hypothesis that Dupuytren disease (DD) is associated with a previously reported mutation in mitochondrial DNA at position 2839.
METHODS: Two hundred sixty-nine cases of DD and an equal number of matched controls were identified in Marshfield Clinic's Personalized Medicine Research Project (PMRP). Clinical data used to describe the cohort were abstracted from the electronic medical records of the population. Genetic analysis of all the cases and controls was done using a custom synthesis TaqMan assay, while genetic analysis of sixteen of the above cases with a familial history of DD was performed by mitochondrial DNA sequencing at position C2839A.
RESULTS: Cases and controls were evenly distributed with 167 (62%) men and 102 (38%) women. The majority, 264 (98%) of the cases and controls were white non-Hispanic. Of the 269 cases, 16 were found to have a familial history of DD. Two cases had a maternal history, eight a paternal history, five an affected sibling, and one a paternal grandfather. All cases and controls were found to have only the C allele at the site of the reported mitochondrial C2839A polymorphism.
CONCLUSIONS: The previously reported mitochondrial mutation was not present in our small, maternally inherited cohort or in the total population of 538 cases and controls. This finding does not support the reported incidence of this polymorphism in 90% of the affected population with a maternal inheritance, and calls into question the role of the C2839A mitochondrial DNA polymorphism in familial or sporadic cases of DD.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22634541      PMCID: PMC3421422          DOI: 10.3121/cmr.2012.1063

Source DB:  PubMed          Journal:  Clin Med Res        ISSN: 1539-4182


  19 in total

1.  PCR screening for common weak D types shows different distributions in three Central European populations.

Authors:  T H Müller; F F Wagner; A Trockenbacher; N I Eicher; W A Flegel; D Schönitzer; F Schunter; C Gassner
Journal:  Transfusion       Date:  2001-01       Impact factor: 3.157

Review 2.  Mitochondrial respiratory dysfunction-elicited oxidative stress and posttranslational protein modification in mitochondrial diseases.

Authors:  Yu-Ting Wu; Shi-Bei Wu; Wan-Yu Lee; Yau-Huei Wei
Journal:  Ann N Y Acad Sci       Date:  2010-07       Impact factor: 5.691

3.  Wnt signaling and Dupuytren's disease.

Authors:  Guido H Dolmans; Paul M Werker; Hans C Hennies; Dominic Furniss; Eleonora A Festen; Lude Franke; Kerstin Becker; Pieter van der Vlies; Bruce H Wolffenbuttel; Sigrid Tinschert; Mohammad R Toliat; Michael Nothnagel; Andre Franke; Norman Klopp; H-Erich Wichmann; Peter Nürnberg; Henk Giele; Roel A Ophoff; Cisca Wijmenga
Journal:  N Engl J Med       Date:  2011-07-06       Impact factor: 91.245

4.  The expression of platelet-derived growth-factor gene in Dupuytren contracture.

Authors:  R M Terek; W A Jiranek; M J Goldberg; H J Wolfe; B A Alman
Journal:  J Bone Joint Surg Am       Date:  1995-01       Impact factor: 5.284

5.  Identification of a novel mitochondrial mutation in Dupuytren's disease using multiplex DHPLC.

Authors:  Ardeshir Bayat; Joanne Walter; Helen Lambe; James S Watson; John K Stanley; Michael Marino; Mark W J Ferguson; William E R Ollier
Journal:  Plast Reconstr Surg       Date:  2005-01       Impact factor: 4.730

6.  Genetic susceptibility to Dupuytren's disease: transforming growth factor beta receptor (TGFbetaR) gene polymorphisms and Dupuytren's disease.

Authors:  A Bayat; J K Stanley; J S Watson; M W J Ferguson; W E R Ollier
Journal:  Br J Plast Surg       Date:  2003-06

7.  Extreme heterogeneity in CARD15 and DLG5 Crohn disease-associated polymorphisms between German and Norwegian populations.

Authors:  Valentina Medici; Silvia Mascheretti; Peter J P Croucher; Monika Stoll; Jochen Hampe; Jochen Grebe; Giacomo C Sturniolo; Camilla Solberg; Jorgen Jahnsen; Bjorn Moum; Stefan Schreiber; Morten H Vatn
Journal:  Eur J Hum Genet       Date:  2006-04       Impact factor: 4.246

8.  Identification of biomarkers in Dupuytren's disease by comparative analysis of fibroblasts versus tissue biopsies in disease-specific phenotypes.

Authors:  Barbara Shih; Dulharie Wijeratne; Daniel J Armstrong; Tommy Lindau; Philip Day; Ardeshir Bayat
Journal:  J Hand Surg Am       Date:  2009-01       Impact factor: 2.230

9.  Expression of a novel gene, MafB, in Dupuytren's disease.

Authors:  Lucy C Lee; Andrew Y Zhang; Alphonsus K Chong; Hung Pham; Michael T Longaker; James Chang
Journal:  J Hand Surg Am       Date:  2006-02       Impact factor: 2.230

10.  Prevalence, incidence, and treatments of Dupuytren's disease in the United States: results from a population-based study.

Authors:  Dana Britt Dibenedetti; Dat Nguyen; Laurie Zografos; Ryan Ziemiecki; Xiaolei Zhou
Journal:  Hand (N Y)       Date:  2010-11-16
View more
  4 in total

1.  Structure of the large ribosomal subunit from human mitochondria.

Authors:  Alan Brown; Alexey Amunts; Xiao-Chen Bai; Yoichiro Sugimoto; Patricia C Edwards; Garib Murshudov; Sjors H W Scheres; V Ramakrishnan
Journal:  Science       Date:  2014-10-02       Impact factor: 47.728

2.  The Effect of Shock Wave Therapy on Improving the Symptoms and Function of Patients with Dupuytren's Contracture.

Authors:  Parisa Taheri; Najmeh Salek; Maryam Mousavi; Razieh Maghroori
Journal:  Adv Biomed Res       Date:  2022-01-31

3.  RNA sequencing reveals a depletion of collagen targeting microRNAs in Dupuytren's disease.

Authors:  Scott M Riester; Diren Arsoy; Emily T Camilleri; Amel Dudakovic; Christopher R Paradise; Jared M Evans; Jorge Torres-Mora; Marco Rizzo; Peter Kloen; Marianna Kruithof-de Julio; Andre J van Wijnen; Sanjeev Kakar
Journal:  BMC Med Genomics       Date:  2015-10-07       Impact factor: 3.063

4.  The presence of highly disruptive 16S rRNA mutations in clinical samples indicates a wider role for mutations of the mitochondrial ribosome in human disease.

Authors:  Joanna L Elson; Paul M Smith; Laura C Greaves; Robert N Lightowlers; Zofia M A Chrzanowska-Lightowlers; Robert W Taylor; Antón Vila-Sanjurjo
Journal:  Mitochondrion       Date:  2015-09-05       Impact factor: 4.160

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.